SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-04-000561
Filing Date
2004-02-26
Accepted
2004-02-25 17:37:18
Documents
1
Group Members
ORBIMED ADVISORS LLCORBIMED CAPITAL II LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D - ORBIMED CAPITAL LLC sc13d_022304-biocryspharminc.txt SC 13D 464750
  Complete submission text file 0000947871-04-000561.txt   466720
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PKWY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-44055 | Film No.: 04628390
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 787 THIRD AVE 30TH FL NEW YORK NY 10017
Business Address
ORBIMED CAPITAL II LLC (Filed by) CIK: 0001281668 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231